Hutchison Chi-Med | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (41)

View All

Latest Posts

About This Stock More About This Stock
Week In Review: ProfoundBio, A Seattle-Suzhou ADC Biotech, Acquired By Genmab For $1.8 Billion
Article By: ChinaBio® Today
Saturday, April 6, 2024 1:20 PM EDT
ProfoundBio will be acquired by Copenhagen’s Genmab A/S in a $1.8 billion all-cash deal. The acquisition will expand Genmab’s drug portfolio, including three ProfoundBio clinical stage ADC candidates for solid tumors.
In this article: INCY, GMAB, CHSYF, BMY, HCM, ZLAB, IVBXF Also: ASND
Read
Week In Review: Shanghai Inmagene Signs $230 Million Deal To Develop Two HutchMed Immunology Assets
Article By: ChinaBio® Today
Saturday, February 3, 2024 2:40 PM EDT
Inmagene Biopharma of Shanghai transferred 7.5% of its shares to HutchMed for global rights to two clinical stage immunology assets. It will also be responsible for up to $230 million in milestones.
In this article: SNY, HCM, BNTX, GRCL
Read
Week In Review: A Consortium Of China Drug Distributors Want To Acquire Poland's Neuca
Article By: ChinaBio® Today
Saturday, August 26, 2023 1:59 PM EDT
China’s drug distributors are in the hunt to acquire Poland’s Neuca, a company with a 32% market share of Poland’s pharmaceutical distribution business. The consortium of China’s drug distributors may include Sinopharm.
In this article: HCM, IVBXF, SHTDY Also: PFE, MRNA
Read
Week In Review: HutchMed Announces $1.1 Billion Deal With Takeda For Colorectal Cancer Drug
Article By: ChinaBio® Today
Saturday, January 28, 2023 3:00 PM EDT
Shanghai’s HutchMed out-licensed global rights for a colorectal cancer therapy to Japan’s Takeda in a deal worth up to $1.13 billion, including $400 million upfront. In addition to the $1.13 billion, HutchMed will also pay royalties on net sales.
In this article: HCM, TAK Also: SMMT, LEGN, SBHMY, SHJBF, ASCLF
Read
Week In Review: Hansoh In-licenses Endometriosis/Fibroid Therapy In $170 Million Deal
Article By: ChinaBio® Today
Saturday, August 13, 2022 4:15 PM EDT
Other funding deals for drug discovery, R&D, gene editing.
In this article: HCM, LIAN
Read
All Posts

Latest Tweets for $HCM

No tweets yet!

PARTNER HEADLINES